Zydus Lifesciences Ltd (ZYDUSLIFE) — Announcement | 11 September 2026 (2 announcements)

Zydus Lifesciences announced it will attend the J.P. Morgan India Conference on September 21, 2026, as part of its ongoing investor engagement. The filing confirms participation in a major financial conference, highlighting continued focus on investor relations and market visibility. This event provides a platform for management to present strategic updates and financial outlook to analysts and institutional investors.

Zydus Lifesciences announced that CRISIL reaffirmed its long-term rating of CRISIL AAA/Stable and short-term rating of CRISIL A1+ for bank facilities, while confirming no outstanding commercial paper or NCDs exist, maintaining stable outlooks and affirming the company's strong liquidity position.